EurekAlert! -
15 Aug 2018 06:00
(Fundação de Amparo Pesquisa do Estado de São Paulo) A study aiming at the development of a dengue vaccine shows that the prevalence of a virus lineage upon the other does not rely on the highest replication rate: it is rather based on the virus' ability in triggering weaker activation of the patient's immune response.
Share this Article